Direct comparison of bromodeoxyuridine and Ki‐67 labelling indices in human tumours

This publication has 23 references indexed in Scilit:

• Can Ki67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma?
  Journal of Clinical Pathology, 1994
• The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins.
  The Journal of cell biology, 1993
• The relevance of antibody concentration to the immunohistological quantification of cell proliferation‐associated antigens
  Histopathology, 1993
• Proliferating cell nuclear antigen is required for DNA excision repair
  Cell, 1992
• Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC cooperative trial 22851
  Seminars in Radiation Oncology, 1992
• A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction
  The Journal of Pathology, 1991
• Assessment of Human Tumour Proliferation Using Bromodeoxyuridine—Current Status
  Acta Oncologica, 1991
• The cell cycle associated change of the Ki‐67 reactive nuclear antigen expression
  Journal of Cellular Physiology, 1987
• Immunofluorescent quantification of ribonucleotide reductase M1 subunit and correlation with DNA content by flow cytometry
  Cytometry, 1987
• The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry
  Cytometry, 1985